No Data
No Data
No Data
No Data
No Data
Senti Biosciences Announces Executive Team Reshuffle and New CFO
TipRanks04:44
Senti Bio Announces Publication Of SENTI-202 Preclinical Data Demonstrating Potential Of Logic-Gated CAR-NK Cell Therapy For The Treatment Of Acute Myeloid Leukemia
Senti Bio Announces Publication Of SENTI-202 Preclinical Data Demonstrating Potential Of Logic-Gated CAR-NK Cell Therapy For The Treatment Of Acute Myeloid Leukemia
BenzingaApr 30 20:11
Senti Bio Announces Publication of SENTI-202 Preclinical Data; Says Data Supports The Design Of Phase 1 Clinical Trial With Patient Dosing Anticipated In Q2
Senti Bio Announces Publication of SENTI-202 Preclinical Data; Says Data Supports The Design Of Phase 1 Clinical Trial With Patient Dosing Anticipated In Q2
BenzingaApr 30 20:10
Senti Biosciences CFO Resigns, Transitions to Consultancy Role
TipRanksApr 27 05:15
Wolf Popper LLP Announces Investigations on Behalf of Investors in Materially Underperforming Special Purpose Acquisition Companies
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Wolf Popper LLP is investigating potential claims on behalf of investors in the following Special Purpose Acquisition Companies (SPAC). The stock prices of these companies,
GlobeNewswireApr 4 22:40
Senti Biosciences 4Q Rev $0.00 >SNTI
Senti Biosciences 4Q Rev $0.00 >SNTI
Dow JonesMar 22 04:13
No Data
No Data